Data gathered: January 20
AI Stock Analysis - Eli Lilly and Company (LLY)
Analysis generated January 4, 2025. Powered by Chat GPT.
Eli Lilly and Company (NYSE: LLY) is a leading pharmaceutical company known for its innovation in healthcare solutions. Established in 1876, Eli Lilly has a rich history of developing life-changing medications, including drugs for diabetes, cancer, and autoimmune diseases. With a strong focus on research and development, Eli Lilly has consistently delivered new treatments that address critical health challenges globally. The company operates in numerous segments including human pharmaceuticals and animal health, serving markets worldwide.
Stock Alerts - Eli Lilly and Company (LLY)
Eli Lilly and Company | January 18 Reddit mentions are up by 166% in the last 24h. |
|
Eli Lilly and Company | January 15 AI Score is up by 27.1% in the last couple of days. |
|
Eli Lilly and Company | January 15 Reddit mentions are up by 180% in the last 24h. |
|
Eli Lilly and Company | January 15 Josh Gottheimer (member of U.S. congress) is selling shares |
Alternative Data for Eli Lilly and Company
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 1,045 | Sign up | Sign up | Sign up | |
Sentiment | 77 | Sign up | Sign up | Sign up | |
Webpage traffic | 3,957,000 | Sign up | Sign up | Sign up | |
Employee Rating | 82 | Sign up | Sign up | Sign up | |
Google Trends | 38 | Sign up | Sign up | Sign up | |
Patents | 451 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 1,225 | Sign up | Sign up | Sign up | |
Facebook Followers | 250,176 | Sign up | Sign up | Sign up | |
Instagram Followers | 40,320 | Sign up | Sign up | Sign up | |
Reddit Mentions | 17 | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 17 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 23,155 | Sign up | Sign up | Sign up | |
Twitter Followers | 142,851 | Sign up | Sign up | Sign up | |
Twitter Mentions | 129 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | 46 | Sign up | Sign up | Sign up | |
ESG | 66 | Sign up | Sign up | Sign up | |
Business Outlook | 83 | Sign up | Sign up | Sign up | |
Linkedin Employees | 46,826 | Sign up | Sign up | Sign up |
About Eli Lilly and Company
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
Price | $725.72 |
Target Price | Sign up |
Volume | 5,460,000 |
Market Cap | $653B |
Year Range | $725.72 - $958.35 |
Dividend Yield | 0.83% |
PE Ratio | 78.12 |
Analyst Rating | 88% buy |
Earnings Date | February 6 '25 |
Industry | Drug Manufacturers |
In the news
Leerink Partnrs Has Bearish Outlook for LLY FY2024 EarningsJanuary 17 - ETF Daily News |
|
Rep. Josh Gottheimer Sells Off Shares of Eli Lilly and Company (NYSE:LLY)January 16 - ETF Daily News |
|
Eli Lilly and Company (NYSE:LLY) Stock Unloaded Rep. Josh GottheimerJanuary 16 - ETF Daily News |
|
Rep. Josh Gottheimer Sells Eli Lilly and Company (NYSE:LLY) StockJanuary 16 - ETF Daily News |
|
Jim Cramer on Eli Lilly and Company (LLY): ‘There’s Been Some Mistakes’January 15 - Yahoo Entertainment |
|
Buy, Sell, Or Hold LLY Stock At $750?January 15 - Forbes |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q3 '24 | 11.4B | 4.24B | 7.2B | 970M | 2.25B | 1.180 |
Q2 '24 | 11.3B | 4.61B | 6.69B | 2.97B | 4.12B | 3.920 |
Q1 '24 | 8.77B | 3.51B | 5.26B | 2.24B | 3.12B | 2.580 |
Q4 '23 | 9.35B | 4.17B | 5.18B | 2.19B | 3.03B | 2.490 |
Q3 '23 | 9.5B | 3.55B | 5.95B | -57M | 6.4B | 0.100 |
Insider Transactions View All
Zakrowski Donald A filed to sell 5,480 shares at $803.4. November 8 '24 |
LILLY ENDOWMENT INC filed to sell 96,891,978 shares at $969.2. September 4 '24 |
LILLY ENDOWMENT INC filed to sell 96,892,957 shares at $968.3. September 4 '24 |
LILLY ENDOWMENT INC filed to sell 96,894,557 shares at $967.3. September 4 '24 |
LILLY ENDOWMENT INC filed to sell 96,899,877 shares at $966.2. September 4 '24 |
Similar companies
Company | Price | AI Score | |
---|---|---|---|
Johnson & JohnsonJNJ |
$147.03 0% | 46 |
|
PfizerPFE |
$26.3 0% | 38 |
|
AstrazenecaAZN |
$66.6 0% | 54 |
|
AbbVieABBV |
$171.56 0% | 52 |
|
TherapeuticsMDTXMD |
$1.06 0% | 41 |
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
Josh Gottheimer |
Jan 15, 25 | Sell | $1K - $15K |
Josh Gottheimer |
Jan 15, 25 | Sell | $1K - $15K |
Josh Gottheimer |
Jan 15, 25 | Sell | $1K - $15K |
Read more about Eli Lilly and Company (LLY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Eli Lilly and Company?
The Market Cap of Eli Lilly and Company is $653B.
What is Eli Lilly and Company's PE Ratio?
As of today, Eli Lilly and Company's PE (Price to Earnings) ratio is 78.12.
When does Eli Lilly and Company report earnings?
Eli Lilly and Company will report its next earnings on February 6 '25.
What is the current stock price of Eli Lilly and Company?
Currently, the price of one share of Eli Lilly and Company stock is $725.72.
How can I analyze the LLY stock price chart for investment decisions?
The LLY stock price chart above provides a comprehensive visual representation of Eli Lilly and Company's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eli Lilly and Company shares. Our platform offers an up-to-date LLY stock price chart, along with technical data analysis and alternative data insights.
Does LLY offer dividends to its shareholders?
Yes, Eli Lilly and Company (LLY) offers dividends to its shareholders, with a dividend yield of 0.83%. This dividend yield represents Eli Lilly and Company's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Eli Lilly and Company in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Eli Lilly and Company?
Some of the similar stocks of Eli Lilly and Company are Johnson & Johnson, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.
.